| GTO ID | GTC2950 |
| Trial ID | NCT05264974 |
| Disease | Melanoma |
| Therapy | mRNA vaccine |
| Treatment | total tumor mRNA loaded DOTAP liposome Vaccine |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Novel RNA-nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy |
| Year | 2024 |
| Country | United States |
| Company sponsor | University of Florida |
| Other ID(s) | UF-CUT-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||